175 related articles for article (PubMed ID: 25336517)
1. MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer.
Tholey RM; Lal S; Jimbo M; Burkhart RA; Blanco FF; Cozzitorto JA; Eisenberg JD; Jiang W; Iacobuzio-Donahue CA; Witkiewicz AK; Glbert M; Yeo CJ; Brody JR; Sawicki JA; Winter JM
Mol Cancer Res; 2015 Mar; 13(3):439-48. PubMed ID: 25336517
[TBL] [Abstract][Full Text] [Related]
2. Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.
Nath S; Roy LD; Grover P; Rao S; Mukherjee P
Pancreas; 2015 Aug; 44(6):909-17. PubMed ID: 26035123
[TBL] [Abstract][Full Text] [Related]
3. [Human mucin 1 promoter drives human sodium/iodide symporter gene targeting expression in pancreatic carcinoma cells].
Zhou QB; Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Chen JS
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2780-4. PubMed ID: 18167272
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells.
Showalter SL; Huang YH; Witkiewicz A; Costantino CL; Yeo CJ; Green JJ; Langer R; Anderson DG; Sawicki JA; Brody JR
Cancer Biol Ther; 2008 Oct; 7(10):1584-90. PubMed ID: 19039293
[TBL] [Abstract][Full Text] [Related]
5. A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.
Winter JM; Tang LH; Klimstra DS; Brennan MF; Brody JR; Rocha FG; Jia X; Qin LX; D'Angelica MI; DeMatteo RP; Fong Y; Jarnagin WR; O'Reilly EM; Allen PJ
PLoS One; 2012; 7(7):e40157. PubMed ID: 22792233
[TBL] [Abstract][Full Text] [Related]
6. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
[TBL] [Abstract][Full Text] [Related]
7. Data-Driven Prioritization and Review of Targets for Molecular-Based Theranostic Approaches in Pancreatic Cancer.
Koller M; Hartmans E; de Groot DJA; Zhao XJ; van Dam GM; Nagengast WB; Fehrmann RSN
J Nucl Med; 2017 Dec; 58(12):1899-1903. PubMed ID: 29051346
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional tumor-selective promoter targeting of E. coli purine nucleoside phosphorylase for pancreatic cancer suicide gene therapy.
Deharvengt S; Wack S; Aprahamian M; Hajri A
J Gene Med; 2005 May; 7(5):672-80. PubMed ID: 15580629
[TBL] [Abstract][Full Text] [Related]
9. Expression of KL-6/MUC1 in pancreatic cancer tissues and its potential involvement in tumor metastasis.
Xu H; Inagaki Y; Seyama Y; Du G; Wang F; Kokudo N; Tang W
Oncol Rep; 2011 Aug; 26(2):371-6. PubMed ID: 21617869
[TBL] [Abstract][Full Text] [Related]
10. In vivo radioiodide imaging and treatment of pancreatic cancer xenografts after MUC1 promoter-driven expression of the human sodium-iodide symporter.
Chen RF; Li ZH; Pan QH; Zhou JJ; Tang QB; Yu FY; Zhou QB; Wang J; Chen JS
Pancreatology; 2007; 7(5-6):505-13. PubMed ID: 17912014
[TBL] [Abstract][Full Text] [Related]
11. Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma.
Yazdanifar M; Zhou R; Grover P; Williams C; Bose M; Moore LJ; Wu ST; Maher J; Dreau D; Mukherjee AP
Cells; 2019 Sep; 8(9):. PubMed ID: 31514488
[TBL] [Abstract][Full Text] [Related]
12. Heat-induced transcription of diphtheria toxin A or its variants, CRM176 and CRM197: implications for pancreatic cancer gene therapy.
Fogar P; Navaglia F; Basso D; Zambon CF; Moserle L; Indraccolo S; Stranges A; Greco E; Fadi E; Padoan A; Pantano G; Sanzari MC; Pedrazzoli S; Montecucco C; Plebani M
Cancer Gene Ther; 2010 Jan; 17(1):58-68. PubMed ID: 19609296
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
[TBL] [Abstract][Full Text] [Related]
14. Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences.
Amit D; Hochberg A
J Transl Med; 2010 Dec; 8():134. PubMed ID: 21162716
[TBL] [Abstract][Full Text] [Related]
15. Activation of Vitamin D/VDR Signaling Reverses Gemcitabine Resistance of Pancreatic Cancer Cells Through Inhibition of MUC1 Expression.
Wei D; Wang L; Liu Y; Hafley MA; Tan L; Lorenzi PL; Yang P; Zuo X; Bresalier RS
Dig Dis Sci; 2023 Jul; 68(7):3043-3058. PubMed ID: 37071246
[TBL] [Abstract][Full Text] [Related]
16. MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors.
Kitamoto S; Yokoyama S; Higashi M; Yamada N; Takao S; Yonezawa S
Oncogene; 2013 Sep; 32(39):4614-21. PubMed ID: 23108411
[TBL] [Abstract][Full Text] [Related]
17. Biphasic Alterations in Expression and Subcellular Localization of MUC1 in Pancreatic Ductal Carcinogenesis in Syrian Hamsters.
Kitahashi T; Takahashi M; Imai T
Pancreas; 2015 Jan; 44(1):76-86. PubMed ID: 25036908
[TBL] [Abstract][Full Text] [Related]
18. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
[TBL] [Abstract][Full Text] [Related]
19. Amplification and functional characterization of MUC1 promoter and gene-virotherapy via a targeting adenoviral vector expressing hSSTR2 gene in MUC1-positive Panc-1 pancreatic cancer cells in vitro.
Chen L; Liu Q; Qin R; Le H; Xia R; Li W; Kumar M
Int J Mol Med; 2005 Apr; 15(4):617-26. PubMed ID: 15754023
[TBL] [Abstract][Full Text] [Related]
20. MUC1 regulates PDGFA expression during pancreatic cancer progression.
Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P
Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
